Document Detail


Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin.
MedLine Citation:
PMID:  19394042     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine the effects of nausea and vomiting of pregnancy (NVP) and its treatment with diclectin on child neurodevelopment. STUDY DESIGN: An observational cohort study of mother-child pairs ascertained via a pregnancy call-in center was conducted. Three groups of children were studied: 45 with NVP and diclectin, 47 with NVP no diclectin, and 29 with no NVP. Phone calls to mothers during pregnancy and 6 to 9 months after childbirth yielded information on pregnancy, birth, and early child development. Children aged 3 to 7 years received a comprehensive set of psychological tests. Mothers were assessed for IQ and socioeconomic status. RESULTS: All children scored in the normal range for IQ, with the NVP-exposed group scoring higher than the non-exposed group on Performance IQ (P < .02), NEPSY Verbal Fluency (P < .003) and Phonological Processing (P < .004), and McCarthy Numerical Memory (P < .004). Predictors of enhanced results were NVP severity and maternal IQ. CONCLUSIONS: NVP has an enhancing effect on later child outcome. Diclectin does not appear to adversely affect fetal brain development and can be used to control NVP when clinically indicated.
Authors:
Irena Nulman; Joanne Rovet; Maru Barrera; Dafna Knittel-Keren; Brian M Feldman; Gideon Koren
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-04-24
Journal Detail:
Title:  The Journal of pediatrics     Volume:  155     ISSN:  1097-6833     ISO Abbreviation:  J. Pediatr.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-29     Completed Date:  2009-07-22     Revised Date:  2009-10-16    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  45-50, 50.e1-2     Citation Subset:  AIM; IM    
Affiliation:
Department of Clinical Pharmacology, Hospital for Sick Children, Toronto, Ontario, Canada. inulman@sickkids.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antiemetics / therapeutic use*
Child
Child Development
Child, Preschool
Cohort Studies
Doxylamine / therapeutic use
Drug Combinations
Female
Humans
Intelligence*
Intelligence Tests
Linear Models
Maternal-Fetal Exchange
Nausea / drug therapy*
Pregnancy
Pregnancy Complications / drug therapy*
Pyridoxine / therapeutic use
Severity of Illness Index
Sleep
Vomiting / drug therapy*
Chemical
Reg. No./Substance:
0/Antiemetics; 0/Drug Combinations; 0/doxylamine, pyridoxine drug combination; 469-21-6/Doxylamine; 65-23-6/Pyridoxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neurobehavior at term and white and gray matter abnormalities in very preterm infants.
Next Document:  Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for ...